As expected, GJA1 was upregulated and CTGF, MMP7, and CCL5 were downregulated by TSN to alleviate kidney fibrosis in DN, and these targets were demonstrated to be engaged in the treatment. This evidence concerns the gene GJA1 and liver dysplastic nodule.